Charles Theuer, President and CEO at Tracon Pharmaceuticals, Inc. (TCON), bought 9,200 shares at $1.52 ($14K) on 2022-11-03, disclosed to the SEC on 2022-11-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| TCON | BUY | 2023-01-19 | $11K | — | Filing → |
| TCON | BUY | 2022-12-15 | $30K | — | Filing → |
| TCON | BUY | 2022-11-22 | $20K | — | Filing → |